| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2543931 | Journal of the American Pharmacists Association | 2006 | 6 Pages |
Abstract
Given appropriate legislative or other facilitatory actions, a royalty-based system for the marketing of generic products after the expiration of initial patents has the potential to promote innovation, provide for more thorough clinical studies, reduce prices, and share know-how. In addition, some of the issues related to the so-called aggressive pharmaceutical marketing practices would be resolved.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Hamida K. BPharm, Abu T.M. BPharm, PhD, FAPhA,